miR-26b-5p regulates hypoxia-induced phenotypic switching of vascular smooth muscle cells via the TGF-β/Smad4 signaling pathway

Ruan,Changwu; Lu,Jide; Wang,Hairong; Ge,Zhiru; Zhang,Chenjun; Xu,Maochun

doi:10.3892/mmr.2017.6509

miR-26b-5p regulates hypoxia-induced phenotypic switching of vascular smooth muscle cells via the TGF-β/Smad4 signaling pathway

Authors:
- Changwu Ruan
- Jide Lu
- Hairong Wang
- Zhiru Ge
- Chenjun Zhang
- Maochun Xu
View Affiliations

Affiliations: Department of Cardiology, Gongli Hospital, Shanghai 200135, P.R. China
Published online on: April 25, 2017 https://doi.org/10.3892/mmr.2017.6509
Pages: 4185-4190

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia contributes to the phenotypic switch of vascular smooth muscle cells (VSMCs). Various microRNAs (miRNAs) participate in this process as post‑transcriptional regulators, however the mechanism remains unclear. In the present study, mouse VSMCs (mVSMCs) harvested from aortas were cultured in normoxic and hypoxic conditions, and the mRNA levels of miR-26b-5p, desmin, H‑caldesmon and smoothelin were quantified using reverse transcription‑quantitative polymerase chain reaction. Following treatment with a miR‑26b‑5p antagonist (agomir) or non‑targeting control (scramble), the cell areas of normoxic and hypoxic mVSMCs were analyzed by immunofluorescence staining. In addition, the protein expression levels of collagen Iα, Smad2/phosphorylated (p)‑Smad2, Smad3/p‑Smad3 and Smad4 were determined by western blotting. Potential miRNA26b‑5p binding sequences in the 3'‑untranslated region (UTR) of Smad4 were investigated, and the distribution of Smad4 in mVSMCs was visualized using immunofluorescence methods. Hypoxic mVSMCs exhibited a significant downregulation miR‑26b‑5p, upregulation of hypoxia inducible factor‑1α mRNA and suppression of desmin, H‑caldesmon and smoothelin mRNA levels. Additionally, miR‑26b‑5p agomir reduced the cell area and decreased collagen Iα expression levels in hypoxic mVSMCs compared with normoxic mVSMCs transfected with agomir, and the area was comparable with those of normoxic mVSMCs transfected with agomir or scramble. Furthermore, miR‑26b‑5p suppressed Smad4 expression in hypoxic mVSMCs, but did not change the expression levels of Smad2 and Smad3, p‑Smad2 and p‑Smad3, however p‑Smad2 and p‑Smad3 levels were upregulated in response to hypoxic stimuli. Additionally, the miR‑26b‑5p agomir caused weak immunoreactivity with Smad4 in hypoxic mVSMCs. The binding motif of miR‑26b‑5p in the Smad4 3'‑UTR was identified as UACUUGA at position 978-984. These findings suggest that miR‑26b‑5p regulates hypoxia‑induced phenotypic switching of VSMCs via the transforming growth factor β/Smad4 signaling pathway.

View Figures

View References

1	Alexander MR and Owens GK: Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 74:13–40. 2012. View Article : Google Scholar
2	Chamley-Campbell J, Campbell GR and Ross R: The smooth muscle cell in culture. Physiol Rev. 59:1–61. 1979.
3	Thyberg J, Hedin U, Sjölund M, Palmberg L and Bottger BA: Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:966–90. 1990. View Article : Google Scholar
4	Nikkari ST, Rantala I, Pystynen P and Nikkari T: Characterization of the phenotype of smooth muscle cells in human fetal aorta on the basis of ultrastructure, immunofluorescence, and the composition of cytoskeletal and cytocontractile proteins. Atherosclerosis. 74:33–40. 1988. View Article : Google Scholar
5	Yin H, Li Q, Qian G, Wang Y, Li Y, Wu G and Wang G: Rab1 GTPase regulates phenotypic modulation of pulmonary artery smooth muscle cells by mediating the transport of angiotensin II type 1 receptor under hypoxia. Int J Biochem Cell Biol. 43:401–408. 2011. View Article : Google Scholar
6	Jie W, Guo J, Shen Z, Wang X, Zheng S, Wang G and Ao Q: Contribution of myocardin in the hypoxia-induced phenotypic switching of rat pulmonary arterial smooth muscle cells. Exp Mol Pathol. 89:301–306. 2010. View Article : Google Scholar
7	Kim K, Yang DK, Kim S and Kang H: miR-142-3p is a regulator of the TGFβ-mediated vascular smooth muscle cell phenotype. J Cell Biochem. 116:2325–2333. 2015. View Article : Google Scholar
8	Kim S, Hata A and Kang H: Down-regulation of miR-96 by bone morphogenetic protein signaling is critical for vascular smooth muscle cell phenotype modulation. J Cell Biochem. 115:889–895. 2014. View Article : Google Scholar :
9	Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R and Raj JU: MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol. 299:L861–L871. 2010. View Article : Google Scholar :
10	Brock M, Haider TJ, Vogel J, Gassmann M, Speich R, Trenkmann M, Ulrich S, Kohler M and Huber LC: The hypoxia-induced microRNA-130a controls pulmonary smooth muscle cell proliferation by directly targeting CDKN1A. Int J Biochem Cell Biol. 61:129–37. 2015. View Article : Google Scholar
11	Yuan B, Yu WY, Dai LS, Gao Y, Ding Y, Yu XF, Chen J and Zhang JB: Expression of microRNA-26b and identification of its target gene EphA2 in pituitary tissues in Yanbian cattle. Mol Med Rep. 12:5753–5761. 2015.
12	Xu G, Ji C, Song G, Shi C, Shen Y, Chen L, Yang L, Zhao Y and Guo X: Obesity-associated microRNA-26b regulates the proliferation of human preadipocytes via arrest of the G1/S transition. Mol Med Rep. 12:3648–3654. 2015.
13	Lamberti M, Capasso R, Lombardi A, Di Domenico M, Fiorelli A, Feola A, Perna AF, Santini M, Caraglia M and Ingrosso D: Two different Serum MiRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma Patients. PLoS One. 10:e01353312015. View Article : Google Scholar :
14	Li Y, Wang Y, Yu L, Sun C, Cheng D, Yu S, Wang Q, Yan Y, Kang C, Jin S, et al: miR-146b-5p inhibits glioma migration and invasion by targeting MMP16. Cancer Lett. 339:260–269. 2013. View Article : Google Scholar
15	Prabhakar NR and Semenza GL: Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev. 92:967–1003. 2012. View Article : Google Scholar :
16	Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell. 148:399–408. 2012. View Article : Google Scholar :
17	Haeberle JR: Thin-filament linked regulation of smooth muscle myosin. J Muscle Res Cell Motil. 20:363–370. 1999. View Article : Google Scholar
18	Morgan KG and Gangopadhyay SS: Invited review: Cross-bridge regulation by thin filament-associated proteins. J Appl Physiol. 91:953–962. 2001.
19	Niessen P, Rensen S, Van Deursen J, De Man J, De Laet A, Vanderwinden JM, Wedel T, Baker D, Doevendans P, Hofker M, et al: Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology. 129:1592–1601. 2005. View Article : Google Scholar
20	Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, Spicer DB, Vary CP and Liaw L: Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem. 285:17556–17563. 2010. View Article : Google Scholar :
21	Rodríguez-Vita J, Sánchez-Galán E, Santamaría B, Sánchez-López E, Rodrigues-Díez R, Blanco-Colio LM, Egido J, Ortiz A and Ruiz-Ortega M: Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation. PLoS One. 3:e39592008. View Article : Google Scholar :
22	Yang G and Yang X: Smad4-mediated TGF-beta signaling in tumorigenesis. Int J Biol Sci. 6:1–8. 2010. View Article : Google Scholar :
23	Stone JD, Holt AW, Vuncannon JR, Brault JJ and Tulis DA: AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: Implications for a Smad-3-dependent mechanism. Am J Physiol Heart Circ Physiol. 309:H1251–H1259. 2015. View Article : Google Scholar :
24	Martin-Garrido A, Williams HC, Lee M, Seidel-Rogol B, Ci X, Dong JT, Lassègue B, Martín AS and Griendling KK: Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One. 8:e796572013. View Article : Google Scholar :
25	Huang D, Wang Y, Wang L, Zhang F, Deng S, Wang R, Zhang Y and Huang K: Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell. PLoS One. 6:e271232011. View Article : Google Scholar :
26	Mao X, Debenedittis P, Sun Y, Chen J, Yuan K, Jiao K and Chen Y: Vascular smooth muscle cell Smad4 gene is important for mouse vascular development. Arterioscler Thromb Vasc Biol. 32:2171–2177. 2012. View Article : Google Scholar :